As such, we hypothesize that downstream phosphoprotein expression profiling could be a preferable method of identifying tumours with elevated PI3K pathway activation compared with PIK3CA mutation identification alone, particularly in key proteins such as mTOR and S6RP, both of which can be activated by multiple redundancies and cross-talk with other pathways including the MEK pathway. Here, MTOR is linked to neoplasm.